Electrolyte-induced compositional heterogeneity: A novel approach for rate-controlled oral drug delivery
Authors:
- Viness PillayVPViness Pillay
- Reza FassihiRFReza Fassihi
- 1 November 1999
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 88 (11) , 1140-1148
Abstract
In this work a new approach for in situ interactions between drug and electrolyte(s) is devised to control the release of highly water soluble drugs from oral hydrophilic monolithic systems. The model drug diltiazem hydrochloride (water solubility in excess of 50% at 25 degrees C), in conjunction with specific electrolytes, was principally employed in the design of swellable tablet formulations comprised of hydrophilic polymers such as hydroxypropylmethlcellulose (HPMC) or poly(ethylene oxide) (PEO). Electrolytes such as sodium bicarbonate or pentasodium tripolyphosphate were used to modulate intragel pH dynamics, swelling kinetics, and gel properties. Through in situ ionic interactions (an intragel matrix system composed of different chemical species that promote competition for water of hydration), a compositionally heterogeneous structure referred to as a "metamorphic scaffold" was established. It is shown that this latter structure results in the inhibition of drug dissolution, induction of a differential swelling rate, and attainment of "matrix stiffening" and axially provides a uniform gel layer. Presence of such phases in matrix structure and its influence on swelling dynamics enabled control of diltiazem hydrochloride release in a zero-order manner in different pH environments over a 24-h period. From kinetic analysis using the power law expressions [M(t)/M(infinity) = k(1)t(n), M(t)/M(infinity) = k(1)t(n) + k(2)t(2)(n)] and Hopfenberg model [M(t)/M(infinity) = 1 - (1 - k(1)t)(n)], it became apparent that the dynamics of matrix relaxation and controlled erosion were major factors involved in the release mechanism, while the composite rate constant k(1) (in Hopfenberg model) decreased by approximately 2-fold in the presence of electrolyte(s). These findings indicated that the dynamics of swelling and gel formation in the presence of ionizable species within hydrophilic matrices provide an attractive alternative for zero-order drug delivery from a simple monolithic system.Keywords
This publication has 16 references indexed in Scilit:
- Determination of Continuous Changes in the Gel Layer Thickness of Poly(ethylene oxide) and HPMC Tablets Undergoing Hydration: A Texture Analysis StudyPharmaceutical Research, 1998
- Development of Controlled-Release SK&F 82526-J Buffer Bead Formulations with Tartaric Acid as the BufferPharmaceutical Development and Technology, 1998
- Control of Poorly Soluble Drug Dissolution in Conditions Simulating the Gastrointestinal Tract Flow. 2. Cocompression of Drugs with BuffersJournal of Pharmaceutical Sciences, 1997
- The Solubility-Modulated Osmotic Pump: In Vitro/in Vivo Release of Diltiazem HydrochloridePharmaceutical Research, 1991
- Retardation of weakly basic drugs with diffusion tabletsInternational Journal of Pharmaceutics, 1990
- Microenvironmental pH control of drug dissolutionInternational Journal of Pharmaceutics, 1989
- Influence of the Buffering Capacity of the Medium on the Dissolution of Drug-Excipient MixturesDrug Development and Industrial Pharmacy, 1989
- Use of Buffers in Matrix Capsule FormulationsDrug Development and Industrial Pharmacy, 1988
- A simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJournal of Controlled Release, 1987
- Dissolution Kinetics of Carboxylic Acids II: Effect of BuffersJournal of Pharmaceutical Sciences, 1981